Literature DB >> 3020441

Variation in behavioral response to baclofen: correlation with benzodiazepine binding sites in mouse forebrain.

L Rägo, R A Kiivet, J Harro.   

Abstract

Mice treated with (+/-)baclofen (2 mg/kg i.p.) displayed profound differences to the motor depressant action of this drug. Mice were divided into three groups termed as responders (20%), moderate responders (65%) and nonresponders (15%). No differences were detected in the spontaneous motor activity between the selected groups. When the animal population in the home cages was kept unchanged the different responses to baclofen were reproducible three weeks after selection. A borderline dose of diazepam (1.5 mg/kg) decreased highly significantly motor activity in baclofen responders but failed to do this in nonresponders group. Ex vivo studies with 3H-flunitrazepam (labelling in vivo and binding carried out in vitro) demonstrated that 3H-flunitrazepam binding in mouse forebrain was significantly smaller in baclofen responders than in nonresponders. Further, the apparent number of 3H-flunitrazepam binding sites in vitro was significantly decreased in the forebrain of baclofen responders. It is concluded that some actions of baclofen depend on the functional state of benzodiazepine recognition sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020441     DOI: 10.1007/bf00512945

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The action of stress, beta-carbolines, diazepam, and Ro 15-1788 on GABA receptors in the rat brain.

Authors:  G Biggio
Journal:  Adv Biochem Psychopharmacol       Date:  1983

Review 3.  Drug therapy: spasticity (second of two parts).

Authors:  R R Young; P J Delwaide
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

4.  Effect of GABAergic drugs on benzodiazepine binding site sensitivity in rat cerebral cortex.

Authors:  D W Gallager; J W Thomas; J F Tallman
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

5.  Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms.

Authors:  M D Majewska; D M Chuang
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

Review 6.  Benzodiazepine-GABA receptor-ionophore complex. Current concepts.

Authors:  M K Ticku
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

7.  3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain.

Authors:  D R Hill; N G Bowery
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

8.  Neurochemical characteristics of rats distinguished as benzodiazepine responders and non-responders in a new conflict test.

Authors:  J B Patel; J Stengel; J B Malick; S J Enna
Journal:  Life Sci       Date:  1984-06-25       Impact factor: 5.037

9.  The action of benzodiazepine antagonist Ro 15-1788 on the effects of GABA-ergic drugs.

Authors:  L H Allikmets; L K Rägo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

10.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors.

Authors:  A Guidotti; C M Forchetti; M G Corda; D Konkel; C D Bennett; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  4 in total

1.  GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines.

Authors:  A Agmo; R Pruneda; M Guzmán; M Gutiérrez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

Review 2.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

3.  Correlation between exploratory activity in an elevated plus-maze and number of central and peripheral benzodiazepine binding sites.

Authors:  L Rägo; A Adojaan; J Harro; R A Kiivet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

4.  Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex.

Authors:  L Rägo; R A Kiivet; J Harro; M Pŏld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.